Remus Pharmaceuticals Ltd is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category.
Subscription opens 17 May 2023, closes 19 May 2023. Listing expected 27 May 2023. Apply via ASBA or UPI.
Remus Pharmaceuticals Ltd proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 100 | ₹122,900 |
| Retail (Max) | 13 | 1,300 | ₹1,597,700 |
| sNII (Min) | 14 | 1,400 | ₹1,720,600 |
| bNII (Min) | 68 | 6,800 | ₹8,357,200 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |